Item 8.01 Other Events.

On January 21, 2022, FOMO invested additional funds into GenBio, Inc. ("GenBio"; https://genbioinc.com/), a Delaware corporation that is developing and offering nutraceutical products and formulations aimed at anti-inflammatory and reduced blood pressure health benefits. The Companies are working on health beverages and other products under "FOMO CAN" and other brands, to be distributed by FOMO's minority investment Himalaya Technologies, Inc. (OTC: HMLA; https://www.himalayatechnologies.com/) which directly owned roughly 19.9% of GenBio's pre-money common equity.





Item 9.01. Exhibits



(a) Exhibits. The following exhibits are filed with this Current Report on Form
8-K:



Exhibit No.   Description
10.1            FOMO CORP. - GenBio, Inc. Investment Agreement - January 21,
              2022
10.2            FOMO CORP. - GenBio, Inc. Statement of Positions - January 27,
              2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses